Furthermore, CSMD1 mutations occurred in three of the seven cases, which in melanoma produce neoantigens mimicking bacteria (Burkholderia pseudomallei), a positive predictor for anti-CTL4 therapy [44]. The gene discussed is SLC44A4; the disease is melanoma.